share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Vivos Therapeutics | 4:持股变动声明-高管 Amman Bradford K.
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心信息
Bradford K. Amman, the Chief Financial Officer of Vivos Therapeutics, Inc. (VVOS), has engaged in a transaction involving the company's common stock on June 20, 2024. Following the transaction, Amman directly holds a total of 80 shares of Vivos Therapeutics. The nature of the shares is direct, indicating personal ownership. The transaction details, including the number of shares transacted and the price, have not been disclosed. This financial activity is part of the regular disclosure of stock transactions by company insiders, which can be an indicator of the company's financial health and management's confidence in the business.
Bradford K. Amman, the Chief Financial Officer of Vivos Therapeutics, Inc. (VVOS), has engaged in a transaction involving the company's common stock on June 20, 2024. Following the transaction, Amman directly holds a total of 80 shares of Vivos Therapeutics. The nature of the shares is direct, indicating personal ownership. The transaction details, including the number of shares transacted and the price, have not been disclosed. This financial activity is part of the regular disclosure of stock transactions by company insiders, which can be an indicator of the company's financial health and management's confidence in the business.
Vivos Therapeutics的首席财务官Bradford K. Amman (致富金融(临时代码))于2024年6月20日参与了一项涉及该公司普通股的交易。交易后,Amman直接持有Vivos Therapeutics的80股。股份的性质是直接的,表明个人拥有权益。交易的细节,包括交易股数和价格,尚未披露。这种财务活动是公司内部人员定期披露股票交易的一部分,这可能是公司财务状况和管理层对业务的信恳智能的指标。
Vivos Therapeutics的首席财务官Bradford K. Amman (致富金融(临时代码))于2024年6月20日参与了一项涉及该公司普通股的交易。交易后,Amman直接持有Vivos Therapeutics的80股。股份的性质是直接的,表明个人拥有权益。交易的细节,包括交易股数和价格,尚未披露。这种财务活动是公司内部人员定期披露股票交易的一部分,这可能是公司财务状况和管理层对业务的信恳智能的指标。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息